(Q35688911)

9 August 2017

Treatment of hypertension and microalbuminuria in children and adolescents with type 1 diabetes mellitus (English)

1 reference

9 August 2017

0 references

Francesco Chiarelli

1

1 reference

9 August 2017

Daniela Trotta

series ordinal

2

1 reference

9 August 2017

Alberto Verrotti

series ordinal

3

1 reference

9 August 2017

Angelika Mohn

series ordinal

4

1 reference

9 August 2017

1 June 2002

1 reference

9 August 2017

1 reference

9 August 2017

3

1 reference

9 August 2017

2

1 reference

9 August 2017

113-124

1 reference

Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas

9 August 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Is microalbuminuria progressive?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Prevention of diabetic renal disease with special reference to microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

The importance of microalbuminuria as an indicator of incipient diabetic nephropathy: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Detection and management of diabetic glomerulopathy in children and adolescents with insulin-dependent diabetes mellitus: need for improved knowledge and better care

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Microalbuminuria as prediction of nephropathy in diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

The natural course of microalbuminuria in insulin-dependent diabetes: a 10-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

The predictive value of microalbuminuria in IDDM. A five-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Prevalence of abnormal urinary albumin excretion in adolescents and children with insulin dependent diabetes: the MIDAC study. Microalbinuria in Diabetic Adolescents and Children (MIDAC) research group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

A nation-wide cross-sectional study of urinary albumin excretion rate, arterial blood pressure and blood glucose control in Danish children with type 1 diabetes mellitus. Danish Study Group of Diabetes in Childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Enhanced progression of urinary albumin excretion in IDDM during puberty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Diabetic angiopathy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Risk of nephropathy can be detected before the onset of microalbuminuria during the early years after diagnosis of type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Determinants of progression of microalbuminuria in adolescents with IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Hvidøre Study Group on Childhood Diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Contribution of growth hormone and IGF-I to early diabetic nephropathy in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Genetics of diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Influence of insertion/deletion polymorphism in the ACE-I gene on the progression of diabetic glomerulopathy in type 1 diabetic patients with microalbuminuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Angiotensin II type 1 receptor gene polymorphisms in humans: physiology and pathophysiology of the genotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Relative nocturnal hypertension in children with insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Hypertension in patients with diabetes. Overcoming barriers to effective control

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Prevalence and management of hypertension in type 1 diabetes mellitus in Europe: the EURODIAB IDDM Complications Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Blood pressure does not rise before the onset of microalbuminuria in children followed from diagnosis of type 1 diabetes. Oxford Regional Prospective Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Diabetes and hypertension: how low should you go and with which drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Does microalbuminuria predict diabetic nephropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

The juxtaglomerular apparatus in young type-1 diabetic patients with microalbuminuria. Effect of antihypertensive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Angiotensin II subtype 1 receptor blockers and renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Renoprotection by angiotensin-receptor blockers and ACE inhibitors in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Review of the Overall Experience of Captopril in Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Development and progression of microalbuminuria in a clinic sample of patients with insulin dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with Type I (insulin-dependent) diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

Diabetic nephropathy in children and adolescents: a critical review with particular reference to angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

Predicting diabetic nephropathy in insulin-dependent patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

Incipient nephropathy in type 1 (insulin-dependent) diabetes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

How heterogeneous is microalbuminuria in diabetes mellitus? The case for 'benign' and 'malignant' microalbuminuria

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

Prevalence of microalbuminuria in children with Type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

The prevalence of microalbuminuria in diabetic children and adolescents and its relation to puberty

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

A nationwide cross-sectional study of retinopathy and microalbuminuria in young Norwegian type 1 (insulin-dependent) diabetic patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

Elevated albumin excretion and retinal changes in children with type 1 diabetes are related to long-term poor blood glucose control

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

Relationship between early metabolic control and the development of microalbuminuria--a longitudinal study in children with type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

Puberty as a risk factor for diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

Persistent microalbuminuria in adolescents with type I (insulin-dependent) diabetes mellitus is associated to early rather than late puberty. Results of a prospective longitudinal study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

The natural history of microalbuminuria in adolescents with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

Microalbuminuria is not rare before 5 years of IDDM. EURODIAB IDDM Complications Study Group and the WHO Multinational Study of Vascular Disease in Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

Experimental diabetes increases insulinlike growth factor I and II receptor concentration and gene expression in kidney

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized rats

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

Microalbuminuria in diabetic children and adolescents. Relationship with puberty and growth hormone

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

What is hypertension in diabetes? Ambulatory blood pressure in 137 normotensive and normoalbuminuric Type 1 diabetic patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: results of a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

Follow-up study of glomerular dimensions and cortical interstitium in microalbuminuric type 1 diabetic patients with or without antihypertensive treatment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

Renal arterioles in patients with type I diabetes and microalbuminuria before and after treatment with antihypertensive drugs

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

Enlargement of the juxtaglomerular apparatus in insulin-dependent diabetes mellitus patients with microalbuminuria

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

Enalapril reduces microalbuminuria in young normotensive type 1 (insulin-dependent) diabetic patients irrespective of its hypotensive effect

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30209.X

7 January 2021

10.1034/J.1399-5448.2002.30209.X

Identifiers

DOI

1 reference

release_d6a7ib2u5vgurglyur4i5v46wa

9 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/d6a7ib2u5vgurglyur4i5v46wa

24 November 2022

mapped directly with Wikidata item

1 reference